HemaSphere (Apr 2022)
P20: POLYCENTRIC “REAL LIFE” STUDY OF BELANTAMAB MAFODOTIN FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA
- R Iula,
- F Trastulli,
- R Della Pepa,
- A D’Ambrosio,
- M Romano,
- A Leone,
- G Gaeta,
- S Palmieri,
- S Rocco,
- F Pane,
- F Ferrara,
- L Catalano
Affiliations
- R Iula
- 1 Hematology - Department of Clinical Medicine and Surgery, Federico II University, Naples (Italy)
- F Trastulli
- 2 Division of Hematology and Stem Cell Transplantation Program, AORN Cardarelli Hospital, Naples (Italy)
- R Della Pepa
- 1 Hematology - Department of Clinical Medicine and Surgery, Federico II University, Naples (Italy)
- A D’Ambrosio
- 1 Hematology - Department of Clinical Medicine and Surgery, Federico II University, Naples (Italy)
- M Romano
- 1 Hematology - Department of Clinical Medicine and Surgery, Federico II University, Naples (Italy)
- A Leone
- 1 Hematology - Department of Clinical Medicine and Surgery, Federico II University, Naples (Italy)
- G Gaeta
- 1 Hematology - Department of Clinical Medicine and Surgery, Federico II University, Naples (Italy)
- S Palmieri
- 2 Division of Hematology and Stem Cell Transplantation Program, AORN Cardarelli Hospital, Naples (Italy)
- S Rocco
- 2 Division of Hematology and Stem Cell Transplantation Program, AORN Cardarelli Hospital, Naples (Italy)
- F Pane
- 1 Hematology - Department of Clinical Medicine and Surgery, Federico II University, Naples (Italy)
- F Ferrara
- 2 Division of Hematology and Stem Cell Transplantation Program, AORN Cardarelli Hospital, Naples (Italy)
- L Catalano
- 1 Hematology - Department of Clinical Medicine and Surgery, Federico II University, Naples (Italy)
- DOI
- https://doi.org/10.1097/01.HS9.0000829652.00958.65
- Journal volume & issue
-
Vol. 6
pp. 22 – 22
Abstract
No abstracts available.